Expression Features of TdT in Childhood B-ALL

徐翀,蒋黎敏,李莉,沈立松
DOI: https://doi.org/10.3969/j.issn.1674-8115.2004.06.007
2004-01-01
Abstract:Objective To analyze the expression feature of terminal deoxynucleotidyl transferase (TdT) in acute lymphoblastic leukemia (B-ALL) of childhood B lineage, and to establish the methods using TdT/CD10/CD34/ CD19 quadruple-color staining technique to detect minimal residual disease( MRD) in B-ALL, and to reveal the significance of TdT in the detection of MRD. Methods Seventy children diagnosed with B-ALL were enrolled in our study. The combination TdT/CD10/CD34/CD19 was used to analyze the expression patterns of TdT in B-ALL, and 3 normal bone marrows specimens were set as controls. Patients leukemic cells showed immunophenotypic difference in the TdT vs CD10 dot plots from normal TdT+ CD19 + bone marrow cells, indicating the efficiency of this combination, can be detected in MRD monitoring. This combination was used to the MRD detection at the end of induction therapy and during the continuing therapy. Results Of these 70 patients, 63 (90.0% ) were TdT positive at diagnosis. In the patients diagnosed in common B-ALL, TdT positive cases and the percentage of TdT positive cells were significantly higher than those in the other types of B-ALL. Although most patients showed high expression of TdT and CD34, the percentages of TdT and CD34 expression showed poor correlation. Since the average TdT mean fluorescence intensity (MFI) of the leukemic cells of B-ALL is significantly lower than that of TdT+CD19+ cells in normal bone marrow, it is possible to detect MRD with the TdT marker. TdT/CD10/CD34/CD19 combination can be used to MRD detection with 65. 7% efficientcy , which is higher than that of any other combination. Conclusion The percentages of the expression of TdT and CD34 have poor correlation. The average TdT MFI of B-ALL is significantly lower than that of TdT + CD19 + normal bone marrow cells. This biological feature of B-ALL makes it possible to detect MRD using TdT/CD10/CD34/CD19 combination. This combination suitable for flow cytometric studies of MRD was identified in 46 (65. 7% ) of 70 diagnosed patients. This indicates that TdT/CD10/CD34/CD19 combination is more efficient than any other combination studied. With all these marker combinations in our study, 91.3% of B-lineage ALL cases can be monitored for MRD.
What problem does this paper attempt to address?